Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

JNJ 303

Inquiry
Cat. No.: OB0425LY-246
Synonyms: 878489-28-2; Rel-2-(4-Chlorophenoxy)-2-methyl-N-((1S,2R)-5-(methylsulfonamido)adamantan-2-yl)propanamide; 2-(4-Chlorophenoxy)-N-[(1S,3R)-5-(methanesulfonamido)-2-adamantyl]-2-methylpropanamide; 2-(4-Chlorophenoxy)-2-methyl-N-[5-[(methylsulfonyl)amino]tricyclo[3.3.1.13,7]dec-2-yl]-propanamide
Size: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 200 mg; 500 mg
CAS No.: 878489-28-2
Compound CID: 11575823
JNJ 303

Specification

Description: JNJ 303 is a potent delayed rectifier Kv blocker that potent blocks IKs.
Formula Weight: 440.98
Applications: JNJ 303 can be used in diabetes, obesity and central nervous system research.
Storage: Storage at -20°C.
Formula: C21H29ClN2O4S
Appearance: Solid
Purity: 99.6%, determined by LC-MS.
Solubility: DMSO
Pathway: Membrane transporter/Ion channel
Identity: Confirmed by LC-MS.
Target: Potassium channel

Library Information

Solubility: DMSO
Inquiry

Copyright © Protheragen. All rights reserves.